Variant report

Variant	esv3447654
Chromosome Location	chr4:57395445-57397943
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:160)
CpG islands
(count:305)
Chromatin interactive
region (count:10)
LncRNA
region (count:0)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:160 , 50 per page) page: 1 2 3 4

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr4:57396511-57396521	K562	blood:	n/a	n/a
2	ARID3A	chr4:57395826-57395846	K562	blood:	n/a	n/a
3	BACH1	chr4:57396697-57397216	K562	blood:	n/a	n/a
4	BACH1	chr4:57396656-57397577	H1-hESC	embryonic stem cell:	n/a	n/a
5	BACH1	chr4:57397883-57398378	K562	blood:	n/a	n/a
6	BHLHE40	chr4:57396411-57397382	K562	blood:	n/a	n/a
7	BRCA1	chr4:57396866-57397108	HepG2	liver:	n/a	n/a
8	BRCA1	chr4:57396765-57397275	H1-hESC	embryonic stem cell:	n/a	n/a
9	CBX3	chr4:57396666-57397169	K562	blood:	n/a	n/a
10	CCNT2	chr4:57396474-57397574	K562	blood:	n/a	chr4:57396498-57396518
11	CHD2	chr4:57396531-57398176	K562	blood:	n/a	n/a
12	CHD2	chr4:57396814-57397226	HepG2	liver:	n/a	n/a
13	CHD2	chr4:57396455-57397490	H1-hESC	embryonic stem cell:	n/a	n/a
14	CTCF	chr4:57396320-57396470	SK-N-SH_RA	brain:	n/a	n/a
15	CTCF	chr4:57396852-57397156	K562	blood:	n/a	n/a
16	CTCF	chr4:57397380-57397530	GM12864	blood:	n/a	n/a
17	E2F4	chr4:57396436-57397617	K562	blood:	n/a	chr4:57396834-57396845
18	E2F6	chr4:57396762-57397015	K562	blood:	n/a	n/a
19	E2F6	chr4:57396754-57397267	A549	lung:	n/a	n/a
20	E2F6	chr4:57396572-57398211	K562	blood:	n/a	n/a
21	E2F6	chr4:57396637-57397041	K562	blood:	n/a	n/a
22	E2F6	chr4:57397074-57397432	K562	blood:	n/a	n/a
23	EGR1	chr4:57396089-57396418	K562	blood:	n/a	n/a
24	EP300	chr4:57396691-57397042	K562	blood:	n/a	n/a
25	ETS1	chr4:57396713-57397254	GM12878	blood:	n/a	n/a
26	GATA2	chr4:57396207-57397397	SH-SY5Y	brain:	n/a	chr4:57396301-57396314 chr4:57396498-57396511
27	GTF2B	chr4:57396387-57397046	K562	blood:	n/a	n/a
28	GTF2F1	chr4:57396429-57396522	K562	blood:	n/a	n/a
29	GTF2F1	chr4:57396768-57397083	H1-hESC	embryonic stem cell:	n/a	n/a
30	GTF2F1	chr4:57396764-57397091	K562	blood:	n/a	n/a
31	HCFC1	chr4:57396730-57397360	K562	blood:	n/a	n/a
32	HDAC2	chr4:57396730-57396941	K562	blood:	n/a	n/a
33	HEY1	chr4:57396689-57397293	K562	blood:	n/a	n/a
34	HEY1	chr4:57396711-57397394	K562	blood:	n/a	n/a
35	HMGN3	chr4:57396411-57397408	K562	blood:	n/a	n/a
36	IRF1	chr4:57396723-57397076	K562	blood:	n/a	n/a
37	IRF1	chr4:57396625-57397030	K562	blood:	n/a	n/a
38	IRF1	chr4:57396443-57397141	K562	blood:	n/a	n/a
39	JUND	chr4:57396528-57397071	K562	blood:	n/a	n/a
40	JUND	chr4:57396763-57397165	H1-hESC	embryonic stem cell:	n/a	n/a
41	KAP1	chr4:57396848-57397167	HEK293	kidney:	n/a	n/a
42	MAFF	chr4:57396832-57397189	K562	blood:	n/a	n/a
43	MAFK	chr4:57396464-57396486	K562	blood:	n/a	n/a
44	MAX	chr4:57396703-57397409	SK-N-SH	brain:	n/a	n/a
45	MAX	chr4:57396690-57397209	SK-N-SH	brain:	n/a	n/a
46	MAX	chr4:57397369-57397594	K562	blood:	n/a	n/a
47	MAX	chr4:57397698-57398332	K562	blood:	n/a	n/a
48	MAX	chr4:57396691-57397281	ECC-1	luminal epithelium:	n/a	n/a
49	MAX	chr4:57396494-57396645	K562	blood:	n/a	n/a
50	MAX	chr4:57396713-57397248	A549	lung:	n/a	n/a

(count:305 , 50 per page) page: 1 2 3 4 5 6 7

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr4:57396890-57396940	GM06990	blood:	n/a
2	chr4:57397125-57397175	HEK293	kidney:	embryo
3	chr4:57397423-57397473	BJ	skin:	n/a
4	chr4:57396496-57396546	IMR90	lung:	fetal
5	chr4:57396890-57396940	HRPEpiC	eye:	n/a
6	chr4:57397125-57397175	U87	brain:	n/a
7	chr4:57396496-57396546	GM06990	blood:	n/a
8	chr4:57396890-57396940	BJ	skin:	n/a
9	chr4:57396890-57396940	Hela-S3	cervix:	n/a
10	chr4:57397423-57397473	HAEpiC	amniotic membrane:	n/a
11	chr4:57396496-57396546	HUVEC	blood vessel:	n/a
12	chr4:57396890-57396940	NT2-D1	testis:	n/a
13	chr4:57397125-57397175	AG04450	lung:	fetal
14	chr4:57397423-57397473	SK-N-SH	brain:	n/a
15	chr4:57397423-57397473	HUVEC	blood vessel:	n/a
16	chr4:57397423-57397473	HMEC	breast:	n/a
17	chr4:57396890-57396940	HRE	kidney:	n/a
18	chr4:57397423-57397473	SKMC	muscle:	n/a
19	chr4:57396890-57396940	Caco-2	colon:	n/a
20	chr4:57396496-57396546	AG09309	skin:	n/a
21	chr4:57397016-57397066	HEK293	kidney:	embryo
22	chr4:57397016-57397066	PrEC	prostate:	n/a
23	chr4:57397125-57397175	ProgFib	skin:	n/a
24	chr4:57397423-57397473	HCF	heart:	n/a
25	chr4:57397423-57397473	HepG2	liver:	n/a
26	chr4:57397423-57397473	Hepatocyte	liver:	n/a
27	chr4:57397125-57397175	K562	blood:	n/a
28	chr4:57397125-57397175	SKMC	muscle:	n/a
29	chr4:57397423-57397473	Caco-2	colon:	n/a
30	chr4:57397016-57397066	SK-N-MC	brain:	n/a
31	chr4:57397016-57397066	MCF10A-Er-Src	breast:	n/a
32	chr4:57396496-57396546	AG10803	skin:	n/a
33	chr4:57397423-57397473	NHBE	bronchial:	n/a
34	chr4:57396496-57396546	CMK	blood:	n/a
35	chr4:57396496-57396546	HEK293	kidney:	embryo
36	chr4:57397016-57397066	A549	lung:	n/a
37	chr4:57397125-57397175	A549	lung:	n/a
38	chr4:57396890-57396940	SK-N-SH	brain:	n/a
39	chr4:57396890-57396940	HNPCEpiC	eye:	n/a
40	chr4:57397016-57397066	NB4	blood:	n/a
41	chr4:57397423-57397473	AG09309	skin:	n/a
42	chr4:57397423-57397473	ovcar-3	ovarian:	n/a
43	chr4:57396890-57396940	GM12892	blood:	n/a
44	chr4:57397423-57397473	GM12891	blood:	n/a
45	chr4:57396496-57396546	PANC-1	pancreas:	n/a
46	chr4:57397423-57397473	GM19239	blood:	n/a
47	chr4:57396496-57396546	AG04450	lung:	fetal
48	chr4:57397016-57397066	HRCEpiC	kidney:	n/a
49	chr4:57397423-57397473	K562	blood:	n/a
50	chr4:57397016-57397066	LNCaP	prostate:	n/a

(count:10 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr4:57351069..57353367-chr4:57395076..57396585,2	K562	blood:
2	chr4:57389482..57392280-chr4:57393803..57395923,2	K562	blood:
3	chr4:57297760..57299581-chr4:57396785..57398752,2	MCF-7	breast:
4	chr4:57299474..57303800-chr4:57395386..57399526,7	K562	blood:
5	chr4:57332142..57335262-chr4:57394352..57398997,8	K562	blood:
6	chr4:57396793..57399968-chr4:57400354..57402510,5	K562	blood:
7	chr4:57251883..57253946-chr4:57396755..57399062,3	K562	blood:
8	chr4:57331783..57334990-chr4:57394745..57398997,7	K562	blood:
9	chr4:57331864..57334391-chr4:57396918..57398546,3	MCF-7	breast:
10	chr4:57298757..57303397-chr4:57395270..57398462,7	K562	blood:

No data

Variant related genes	Relation type
THEGL	TF binding region
THEGL	CpG island
ENSG00000174780	chromatin interactions
ENSG00000157426	chromatin interactions
ENSG00000269921	chromatin interactions
ENSG00000128050	chromatin interactions
ENSG00000128059	chromatin interactions

Extended variants
information (count: 88 )
Associated
traits (count: 91 )

Variant overlapped rSNPs/rCNVs (count:88 , 50 per page) page: 1 2

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs535247048	chr4:57395478-57395479	Weak transcription Enhancers	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
2	rs183826460	chr4:57395539-57395540	Weak transcription Enhancers	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
3	rs570339327	chr4:57395552-57395553	Weak transcription Enhancers	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
4	rs547963594	chr4:57395600-57395601	Weak transcription Enhancers	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
5	rs561434577	chr4:57395606-57395607	Weak transcription Enhancers	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
6	rs141328485	chr4:57395608-57395609	Weak transcription Enhancers	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
7	rs536340546	chr4:57395613-57395614	Weak transcription Enhancers	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
8	rs553577265	chr4:57395627-57395628	Weak transcription Enhancers	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
9	rs58459975	chr4:57395662-57395663	Weak transcription Enhancers	Chromatin interactive region	3 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
10	rs112920810	chr4:57395677-57395678	Weak transcription Enhancers	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
11	rs73169318	chr4:57395730-57395731	Weak transcription Enhancers	Chromatin interactive region	3 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
12	rs538987479	chr4:57395787-57395788	Weak transcription Enhancers	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
13	rs559007871	chr4:57395803-57395804	Weak transcription Bivalent Enhancer Enhancers Active TSS	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
14	rs111617795	chr4:57395822-57395823	Weak transcription Bivalent Enhancer Enhancers Active TSS	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
15	rs146860796	chr4:57395830-57395831	Weak transcription Bivalent Enhancer Enhancers Active TSS	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
16	rs376371602	chr4:57395875-57395876	Weak transcription Bivalent Enhancer Enhancers Active TSS	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
17	rs541165146	chr4:57395884-57395885	Weak transcription Bivalent Enhancer Enhancers Active TSS	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
18	rs554637730	chr4:57395968-57395969	Weak transcription Bivalent Enhancer Enhancers Active TSS	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
19	rs75175702	chr4:57396001-57396002	Weak transcription Bivalent Enhancer Enhancers Active TSS	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
20	rs543678460	chr4:57396002-57396003	Weak transcription Bivalent Enhancer Enhancers Active TSS	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
21	rs79401484	chr4:57396033-57396034	Weak transcription Bivalent Enhancer Enhancers Active TSS	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
22	rs60635621	chr4:57396047-57396048	Weak transcription Bivalent Enhancer Enhancers Active TSS	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
23	rs60689316	chr4:57396048-57396049	Weak transcription Bivalent Enhancer Enhancers Active TSS	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
24	rs79815214	chr4:57396133-57396134	Weak transcription Bivalent Enhancer Enhancers Active TSS	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
25	rs115575365	chr4:57396155-57396156	Weak transcription Bivalent Enhancer Enhancers Active TSS	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
26	rs540334084	chr4:57396158-57396159	Weak transcription Bivalent Enhancer Enhancers Active TSS	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
27	rs560154080	chr4:57396163-57396164	Weak transcription Bivalent Enhancer Enhancers Active TSS	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
28	rs60752246	chr4:57396180-57396181	Weak transcription Bivalent Enhancer Enhancers Active TSS	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
29	rs57278339	chr4:57396202-57396203	Bivalent/Poised TSS Weak transcription Active TSS Flanking Active TSS Enhancers Flanking Bivalent TSS/Enh	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
30	rs545067736	chr4:57396225-57396226	Bivalent/Poised TSS Weak transcription Active TSS Flanking Active TSS Enhancers Flanking Bivalent TSS/Enh	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
31	rs34157118	chr4:57396266-57396267	Bivalent/Poised TSS Weak transcription Active TSS Flanking Active TSS Enhancers Flanking Bivalent TSS/Enh	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
32	rs189577516	chr4:57396305-57396306	Bivalent/Poised TSS Weak transcription Active TSS Flanking Active TSS Enhancers Flanking Bivalent TSS/Enh	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
33	rs373306075	chr4:57396313-57396314	Bivalent/Poised TSS Weak transcription Active TSS Flanking Active TSS Enhancers Flanking Bivalent TSS/Enh	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
34	rs545757345	chr4:57396328-57396329	Bivalent/Poised TSS Weak transcription Active TSS Flanking Active TSS Enhancers Flanking Bivalent TSS/Enh	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
35	rs115983201	chr4:57396395-57396396	Bivalent/Poised TSS Weak transcription Active TSS Flanking Active TSS Enhancers Flanking Bivalent TSS/Enh	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
36	rs375375686	chr4:57396396-57396397	Bivalent/Poised TSS Weak transcription Active TSS Flanking Active TSS Enhancers Flanking Bivalent TSS/Enh	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
37	rs531489477	chr4:57396454-57396455	Bivalent/Poised TSS Flanking Active TSS Active TSS Flanking Bivalent TSS/Enh Enhancers	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
38	rs548025806	chr4:57396501-57396502	Bivalent/Poised TSS Flanking Active TSS Active TSS Flanking Bivalent TSS/Enh Enhancers	TF binding region CpG island Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
39	rs58872126	chr4:57396534-57396535	Bivalent/Poised TSS Flanking Active TSS Active TSS Flanking Bivalent TSS/Enh Enhancers	TF binding region CpG island Chromatin interactive region	4 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
40	rs58510494	chr4:57396576-57396577	Bivalent/Poised TSS Flanking Active TSS Active TSS Flanking Bivalent TSS/Enh Enhancers	TF binding region Chromatin interactive region	4 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
41	rs58306036	chr4:57396608-57396609	Bivalent/Poised TSS Enhancers Active TSS Flanking Active TSS Bivalent Enhancer	TF binding region Chromatin interactive region	4 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
42	rs566927077	chr4:57396617-57396618	Bivalent/Poised TSS Enhancers Active TSS Flanking Active TSS Bivalent Enhancer	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
43	rs549230180	chr4:57396665-57396666	Bivalent/Poised TSS Enhancers Active TSS Flanking Active TSS Bivalent Enhancer	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
44	rs146823538	chr4:57396666-57396667	Bivalent/Poised TSS Enhancers Active TSS Flanking Active TSS Bivalent Enhancer	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
45	rs550394641	chr4:57396740-57396741	Bivalent/Poised TSS Enhancers Active TSS Flanking Active TSS Bivalent Enhancer	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
46	rs538684761	chr4:57396753-57396754	Bivalent/Poised TSS Enhancers Active TSS Flanking Active TSS Bivalent Enhancer	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
47	rs28561081	chr4:57396755-57396756	Bivalent/Poised TSS Enhancers Active TSS Flanking Active TSS Bivalent Enhancer	TF binding region Chromatin interactive region	6 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
48	rs568165850	chr4:57396769-57396770	Bivalent/Poised TSS Enhancers Active TSS Flanking Active TSS Bivalent Enhancer	TF binding region Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
49	rs200966785	chr4:57396770-57396771	Bivalent/Poised TSS Enhancers Active TSS Flanking Active TSS Bivalent Enhancer	TF binding region Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
50	rs180891868	chr4:57396803-57396804	Bivalent/Poised TSS Flanking Active TSS Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:91)

Disease	PMID	Source
Gastrointestinal stromal cancer	16982739	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Glioblastoma multiforme	21080181	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Chordoma	21602918	CNVD
HIV/AIDS	22032296	CNVD
Medulloblastoma	21979893	CNVD
Neuroblastoma	18923191	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Intellectual disability	22102821	CNVD
Autism	22495311	CNVD
Breast cancer	21858162	CNVD
Small bowel adenocarcinoma	21586687	CNVD
Gastric cancer	21586687	CNVD
lymphocytic leukemia	21291569	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Non-small cell lung cancer	21829676	CNVD
Melanoma	22183965	CNVD
Melanoma	18172304	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Lung cancer	18438408	CNVD
Renal cell carcinoma	18194544	CNVD
Breast cancer	17603634	CNVD
Glioblastoma multiforme	21922591	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Parkinson disease	21956041	CNVD
Mental retardation	20522426	CNVD
delayed speech	20522426	CNVD
growth disorder	20522426	CNVD
Hepatocellular carcinoma	16750200	CNVD
Myxofibrosarcoma	16751306	CNVD
Esophageal squamous carcinoma	18350619	CNVD
Acute lymphoblastic leukemia	21339820	CNVD
Acute myeloid leukemia	20729466	CNVD
Oral squamous cell carcinoma	17134496	CNVD
Parkinson disease	18923514	CNVD
Non-syndromic sensorineural hearing loss	15273396	CNVD
Cancer	21183584	CNVD
Breast cancer	16272173	CNVD
Glioblastoma multiforme	19435819	CNVD
Multiple myeloma	16616336	CNVD
Colorectal cancer	19359472	CNVD
Malignant mesothelioma	18160781	CNVD
Medulloblastoma	18056178	CNVD
Multiple myeloma	17077331	CNVD
Pleural malignant mesothelioma	18160781	CNVD
Primary mediastinal b-cell lymphoma	17728785	CNVD
4q-syndrome	17576883	CNVD
Cancer	21637783	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Colorectal cancer	20709793	CNVD
Muscular dystrophy	21149563	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Glioblastoma multiforme	19960244	CNVD
Glioblastoma multiforme	17387387	CNVD
Hepatocellular carcinoma	22174799	CNVD
Liposarcoma	21253554	CNVD
Oligodendroglial tumors	17285580	CNVD
Cervical cancer	21062161	CNVD
Myelofibrosis	22110671	CNVD
Glioblastoma multiforme	22286061	CNVD
Malignant fibrous histiocytomas	21085701	CNVD
Ovarian neoplasms	16753589	CNVD
Metanephric adenoma	20802469	CNVD
Breast cancer	16608533	CNVD
Glioblastoma	17504929	CNVD
Glioblastoma	16823502	CNVD
Melanoma	16908931	CNVD
Glioblastoma	20031968	CNVD
Medulloblastoma	19270706	CNVD
Adenoid cystic carcinoma	18698036	CNVD
Olfactory neuroblastoma	18408657	CNVD
Basal cell lymphoma	19029149	CNVD
Diffuse large b-cell lymphoma	19029149	CNVD
Esophageal squamous carcinoma	17470683	CNVD
Rhabdomyosarcoma	16790082	CNVD
Gastrointestinal stromal cancer	17438095	CNVD
Colorectal cancer	16272173	CNVD
Lung cancer	19208797	CNVD
small cell lung cancer	20016488	CNVD
Wilms tumour	21544195	CNVD
Glioblastoma multiforme	21138945	CNVD
Cancer	22183965	CNVD
Breast cancer	21785460	CNVD
Medullary thyroid carcinoma	18765511	CNVD
early-passage human iPS cells	21368824	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
XY gonadal dysgenesis	20685758	CNVD
Non-syndromic sensorineural hearing loss	18451855	CNVD

Chromatin state (count:405 , 50 per page) page: 1 2 3 4 5 6 7 ... 9

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr4:57372600-57396200	Weak transcription	Aorta	Aorta
2	chr4:57372800-57395800	Weak transcription	Breast Myoepithelial Primary Cells	Breast
3	chr4:57373000-57395800	Weak transcription	Brain Anterior Caudate	brain
4	chr4:57373200-57396200	Weak transcription	Fetal Brain Female	brain
5	chr4:57373200-57396400	Weak transcription	H1 Derived Mesenchymal Stem Cells	ES cell derived
6	chr4:57373600-57396200	Weak transcription	Brain Germinal Matrix	brain
7	chr4:57380200-57396200	Weak transcription	Left Ventricle	heart
8	chr4:57381600-57396200	Weak transcription	Right Atrium	heart
9	chr4:57389200-57396000	Weak transcription	Primary hematopoietic stem cells G-CSF-mobilized Female	--
10	chr4:57389200-57396200	Weak transcription	Primary hematopoietic stem cells G-CSF-mobilized Male	--
11	chr4:57395400-57396200	Enhancers	Fetal Heart	heart
12	chr4:57395800-57396000	Enhancers	Breast Myoepithelial Primary Cells	Breast
13	chr4:57395800-57396000	Weak transcription	Stomach Smooth Muscle	stomach
14	chr4:57395800-57396200	Bivalent Enhancer	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
15	chr4:57395800-57396200	Enhancers	Cortex derived primary cultured neurospheres	brain
16	chr4:57395800-57396200	Enhancers	Brain Hippocampus Middle	brain
17	chr4:57395800-57396200	Enhancers	Colon Smooth Muscle	Colon
18	chr4:57395800-57396200	Enhancers	Pancreatic Islets	Pancreatic Islet
19	chr4:57395800-57396200	Enhancers	K562	blood
20	chr4:57395800-57397200	Active TSS	Brain Anterior Caudate	brain
21	chr4:57396000-57396200	Weak transcription	Breast Myoepithelial Primary Cells	Breast
22	chr4:57396000-57396200	Enhancers	Primary hematopoietic stem cells	blood
23	chr4:57396000-57396200	Enhancers	Primary T helper naive cells fromperipheralblood	blood
24	chr4:57396000-57396200	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Female	--
25	chr4:57396000-57396200	Enhancers	Adipose Nuclei	Adipose
26	chr4:57396000-57396200	Enhancers	Fetal Thymus	thymus
27	chr4:57396000-57396200	Enhancers	Stomach Smooth Muscle	stomach
28	chr4:57396200-57396400	Bivalent/Poised TSS	IMR90 fetal lung fibroblasts Cell Line	lung
29	chr4:57396200-57396400	Enhancers	Primary neutrophils fromperipheralblood	blood
30	chr4:57396200-57396400	Enhancers	Primary B cells from peripheral blood	blood
31	chr4:57396200-57396400	Enhancers	Primary T cells fromperipheralblood	blood
32	chr4:57396200-57396400	Enhancers	Primary hematopoietic stem cells short term culture	blood
33	chr4:57396200-57396400	Active TSS	Primary T helper 17 cells PMA-I stimulated	--
34	chr4:57396200-57396400	Enhancers	Primary T cells effector/memory enriched fromperipheralblood	blood
35	chr4:57396200-57396400	Enhancers	Primary Natural Killer cells fromperipheralblood	blood
36	chr4:57396200-57396400	Bivalent/Poised TSS	Fetal Muscle Trunk	muscle
37	chr4:57396200-57396400	Bivalent/Poised TSS	Fetal Muscle Leg	muscle
38	chr4:57396200-57396400	Enhancers	Placenta	Placenta
39	chr4:57396200-57396400	Active TSS	Skeletal Muscle Female	skeletal muscle
40	chr4:57396200-57396400	Enhancers	Thymus	Thymus
41	chr4:57396200-57396400	Flanking Active TSS	HSMM	muscle
42	chr4:57396200-57396600	Flanking Active TSS	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
43	chr4:57396200-57396600	Flanking Active TSS	H9 Derived Neuron Cultured Cells	ES cell derived
44	chr4:57396200-57396600	Flanking Active TSS	Primary B cells from cord blood	blood
45	chr4:57396200-57396600	Flanking Active TSS	Primary T helper naive cells fromperipheralblood	blood
46	chr4:57396200-57396600	Flanking Active TSS	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
47	chr4:57396200-57396600	Flanking Active TSS	Primary hematopoietic stem cells G-CSF-mobilized Female	--
48	chr4:57396200-57396600	Flanking Active TSS	Foreskin Fibroblast Primary Cells skin01	Skin
49	chr4:57396200-57396600	Flanking Active TSS	Adipose Nuclei	Adipose
50	chr4:57396200-57396600	Flanking Bivalent TSS/Enh	Fetal Adrenal Gland	Adrenal Gland

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links